Immatics (IMTX) Accumulated Expenses (2023 - 2025)

Immatics' (IMTX) quarterly Accumulated Expenses came in at $21.5 million in Q4 2025, up 1175.73% year-on-year from $1.7 million in Q4 2024, and up 1175.73% quarter-over-quarter from $1.7 million in Q4 2024.

Immatics (IMTX) Accumulated Expenses (2023 - 2025) Analysis & Trends

Immatics has disclosed Accumulated Expenses across 3 years of filings, most recently posting $21.5 million for Q4 2025.

  • Accumulated Expenses for Q4 2025 came in at $21.5 million, up 1175.73% year-over-year; the trailing twelve-month figure through Dec 2025 was $21.5 million (up 1175.73% YoY), and the FY2025 annual result was $20.9 million, up 1138.21% from the prior year.
  • Accumulated Expenses came in at $21.5 million for Q4 2025 at Immatics, up from $1.7 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $21.5 million in Q4 2025 to a low of $1.4 million in Q4 2023.
  • The 3-year median for Accumulated Expenses is $1.7 million (2024), against an average of $8.2 million.
  • Across the five-year window, Accumulated Expenses grew 22.81% in 2024 and surged 1175.73% in 2025, its largest moves.
  • Immatics' Accumulated Expenses stood at $1.4 million in 2023, then grew by 22.81% to $1.7 million in 2024, then soared by 1175.73% to $21.5 million in 2025.
  • The last three Accumulated Expenses figures came in at $21.5 million (Q4 2025), $1.7 million (Q4 2024), and $1.4 million (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Immatics 14.67 Bn 14.67 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 21.53 Mn
Dec 31, 2024 1.69 Mn
Dec 31, 2023 1.37 Mn